BSEOthers2d ago · 3 Sept 2026, 06:32 pm

Outcome of the Board Meeting on Thursday, 03rd September, 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations, 2015

Norris Medicines Ltd · 524414

✦ AI SummaryResults

Norris Medicines Ltd has announced the outcome of its Board Meeting held on 03rd September, 2026, where the Board approved various matters including the Directors Report, closure of Register of Members, and convening of the 35th Annual General Meeting.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Norris Medicines Ltd - 524414 - Board Meeting Outcome for Of Board Meeting Held On Thurday, 03Rd September, 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.

Attachments (1)

📄

37872d58-575f-4a2f-9710-7f04a5f1833c.pdf

pdf

Download →
View document text
03rd September, 2026 Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. Scrip Code: 524414 Scrip ID: NORRIS Sub: Outcome of Board Meeting held on Thursday, 03rd September, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, Pursuant to Regulation 30 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. We would like to inform you that the Board of Directors of the Company in their meeting held today, i.e., Thursday, 03rd September, 2026, have inter alia, considered, recommended, and approved the following matters: 1. Approved Directors Report along with related annexures of the Company for the Financial Year ended 2025-2026; 2. Approved the closure of Register of Members and Share Transfer Books of the Company for AGM purpose; 3. Approved the cut-off date to record the entitlement of shareholders to cast the votes electronically; 4. Approved convening of the 35th (Thirty Fifth) Annual General Meeting (“AGM”) of the Company for the financial year ended 31st March, 2026 on Tuesday, 29th September, 2026 through Video Conferencing (VC) or Other Audio-Visual Means (OAVM); 5. Approved 35th (Thirty Fifth) Annual Report (including notice of the Company’s AGM) for the financial year 2025 - 2026. 6. Appointment of Mr. Hemant Shetye, Practicing Company Secretary failing of which Mr. Kunal Sakpal, Practicing Company Secretary as a Scrutinizer for conducting the e-Voting process at AGM in fair and transparent manner for the AGM. 7. Approved the appointment of Purva Sharegistry (India) Pvt. Ltd. for facilitating the Evoting process in AGM; 8. Authorized the Directors and / or Company Secretary of the Company to conduct Annual General Meeting and sign and send the Notice along with other documents; Start Time: 4:30 P.M (I.S.T) End Time: 5:30 P.M (I.S.T) Kindly take the same on your record. Thanking you. Yours faithfully FOR NORRIS MEDICINES LIMITED VIMAL D. SHAH DIRECTOR DIN: 0156655